L

Lumos Pharma
D

LUMO

4.32000
USD
0.03
(0.70%)
Market Closed
Volume
200
EPS
-4
Div Yield
-
P/E
-1
Market Cap
37,362,030
News

Title: Lumos Pharma

Sector: Healthcare
Industry: Biotechnology
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnershipswith pharmaceutical companies, and operates in the United States.